UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D. C.
20549
FORM 10-Q
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
FOR THE QUARTERLY PERIOD ENDED September 30,
2020.
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
FOR THE TRANSITION PERIOD FROM __________________ TO
__________________
Commission File No. 333-141875
IGEN Networks
Corp.
|
(Exact
name of registrant as specified in its charter)
|
Nevada
|
|
20-5879021
|
(State or
Other Jurisdiction of
incorporation or organization)
|
|
(I.R.S.
Employer
Identification No.)
|
28375 Rostrata Ave. Lake Elsinore, CA
92532
(Address of principal executive offices) (Zip Code)
1-855-912-5378
(Registrant’s telephone number including area code)
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days: Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted
electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during
the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files). Yes
☒ No ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer,
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large
accelerated filer:
|
☐
|
Accelerated
filer:
|
☐
|
Non-accelerated filer:
|
☐
|
Smaller
reporting company:
|
☒
|
(Do not
check if a smaller reporting company)
|
Emerging
growth company
|
☐
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Act). Yes
☐ No ☒
The number of shares of the registrant’s common stock issued and
outstanding as of November 4, 2020 is 1,162,447,714.
TABLE OF
CONTENTS
Part
I
FINANCIAL INFORMATION
Item 1.
Financial Statements
The Company’s unaudited condensed consolidated interim financial
statements for the three and nine month periods ended September 30,
2020 are included herewith.
IGEN NETWORKS CORP.
Condensed Consolidated Interim Financial Statements
For the Three and Nine Months Ended September 30, 2020
(Unaudited - Expressed in U.S. Dollars)
IGEN NETWORKS CORP.
Condensed Consolidated Interim Balance Sheets
(Expressed in U.S. dollars)
|
|
September 30,
2020
|
|
|
December 31,
2019
|
|
|
|
(unaudited)
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
Assets
|
|
|
|
|
|
|
Cash
|
|
$ |
23,920 |
|
|
$ |
- |
|
Accounts
and other receivables, net
|
|
|
900 |
|
|
|
18,136 |
|
Inventory
|
|
|
11,663 |
|
|
|
4,334 |
|
Prepaid
expenses and deposits
|
|
|
- |
|
|
|
4,013 |
|
Total Current Assets
|
|
|
36,483 |
|
|
|
26,483 |
|
|
|
|
|
|
|
|
|
|
Goodwill
|
|
|
505,508 |
|
|
|
505,508 |
|
Total
Assets
|
|
$ |
541,991 |
|
|
$ |
531,991 |
|
|
|
|
|
|
|
|
|
|
Liabilities
and Stockholders’ Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current
Liabilities
|
|
|
|
|
|
|
|
|
Accounts
payable and accrued liabilities
|
|
$ |
956,661 |
|
|
$ |
983,358 |
|
Current
portion of deferred revenue, net of contract assets
|
|
|
106,282 |
|
|
|
207,566 |
|
Notes
payable
|
|
|
211,605 |
|
|
|
- |
|
Convertible
debentures, net of discount of $44,178 and $343,398,
respectively
|
|
|
18,579 |
|
|
|
21,121 |
|
Derivative
liabilities
|
|
|
102,626 |
|
|
|
92,322 |
|
Total Current Liabilities
|
|
|
1,395,753 |
|
|
|
1,304,367 |
|
|
|
|
|
|
|
|
|
|
Deferred
revenue, net of current portion and contract assets
|
|
|
38,528 |
|
|
|
54,899 |
|
Total
Liabilities
|
|
|
1,434,281 |
|
|
|
1,359,266 |
|
|
|
|
|
|
|
|
|
|
Commitment
and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable
convertible preferred stock - Series A:
|
|
|
|
|
|
|
|
|
Authorized - 9,000,000 shares with $0.001 par value, 205,700 shares
and 160,600 shares issued and outstanding as of September 30, 2020
and December 31, 2019, respectively, net of discount of $142,174
and $121,934, respectively, aggregate liquidation preference of
$209,777 and $153,862 as of September 30, 2020 and December 31,
2019, respectively
|
|
|
35,439 |
|
|
|
31,927 |
|
|
|
|
|
|
|
|
|
|
Stockholders’ Deficit
|
|
|
|
|
|
|
|
|
Series B
preferred stock: Authorized - 1,000,000 shares with $0.001 par
value issued and outstanding - 1,000,000 and 0 shares, as of
September 30, 2020 and December 31, 2019, respectively, aggregate
liquidation preference of $1,000 as of September 30, 2020
|
|
|
1,000 |
|
|
|
- |
|
Common
stock: Authorized - 1,490,000,000 shares with $0.001 par value
issued and outstanding - 1,144,394,069 and 74,242,196 shares, as of
September 30, 2020 and December 31, 2019, respectively
|
|
|
1,144,394 |
|
|
|
74,242 |
|
|
|
|
|
|
|
|
|
|
Additional
paid-in capital
|
|
|
12,896,451 |
|
|
|
10,697,216 |
|
|
|
|
|
|
|
|
|
|
Accumulated
Deficit
|
|
|
(14,969,574 |
) |
|
|
(11,630,660 |
) |
Total
Stockholders’ Deficit
|
|
|
(927,729 |
) |
|
|
(859,202 |
) |
Total
Liabilities and Stockholders’ Deficit
|
|
$ |
541,991 |
|
|
$ |
531,991 |
|
The accompanying notes are an integral part of these condensed
consolidated interim financial statements.
IGEN NETWORKS CORP.
Condensed Consolidated Interim Statements of
Operations
(Unaudited - Expressed in U.S. dollars)
|
|
Three Months
Ended
September
30,
|
|
|
Nine Months
Ended
September
30,
|
|
|
|
2020
|
|
|
2019
|
|
|
2020
|
|
|
2019
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales, services
|
|
$ |
77,996 |
|
|
$ |
150,007 |
|
|
$ |
285,179 |
|
|
$ |
593,885 |
|
Sales, other
|
|
|
- |
|
|
|
- |
|
|
|
8,436 |
|
|
|
- |
|
Total
Revenues
|
|
|
77,996 |
|
|
|
150,007 |
|
|
|
293,615 |
|
|
|
593,885 |
|
Cost of
goods sold
|
|
|
43,118 |
|
|
|
89,732 |
|
|
|
135,662 |
|
|
|
340,853 |
|
Gross
Profit
|
|
|
34,878 |
|
|
|
60,275 |
|
|
|
157,953 |
|
|
|
253,032 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
182,032 |
|
|
|
129,532 |
|
|
|
394,232 |
|
|
|
438,174 |
|
Management and consulting fees
|
|
|
45,112 |
|
|
|
63,375 |
|
|
|
159,948 |
|
|
|
143,273 |
|
Payroll and related
|
|
|
27,318 |
|
|
|
61,596 |
|
|
|
99,557 |
|
|
|
251,305 |
|
Stock-based director expense
|
|
|
- |
|
|
|
- |
|
|
|
277,543 |
|
|
|
- |
|
Total
Expenses
|
|
|
254,462 |
|
|
|
254,503 |
|
|
|
931,280 |
|
|
|
832,752 |
|
Loss Before
Other Income (Expense)
|
|
|
(219,584 |
) |
|
|
(194,228 |
) |
|
|
(773,327 |
) |
|
|
(579,720 |
) |
Other
Income (Expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accretion of discounts on convertible debentures
|
|
|
(9,833 |
) |
|
|
- |
|
|
|
(119,897 |
) |
|
|
- |
|
Change in fair value of derivative liabilities
|
|
|
265,294 |
|
|
|
(94,122 |
) |
|
|
(1,082,407 |
) |
|
|
83,765 |
|
Loss on extinguishment of debt
|
|
|
(29,582 |
) |
|
|
- |
|
|
|
(303,100 |
) |
|
|
- |
|
Interest expense
|
|
|
(33,745 |
) |
|
|
(365,232 |
) |
|
|
(231,188 |
) |
|
|
(485,740 |
) |
Total Other
Income (Expense), net
|
|
|
192,134 |
|
|
|
459,354 |
|
|
|
(1,736,592 |
) |
|
|
(401,975 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss
|
|
|
(27,450 |
) |
|
|
(653,582 |
) |
|
|
(2,509,919 |
) |
|
|
(981,695 |
) |
Increase in
value of warrants
|
|
|
- |
|
|
|
- |
|
|
|
(370,726 |
) |
|
|
- |
|
Accrued and
deemed dividends on redeemable convertible preferred stock
|
|
|
(119,822 |
) |
|
|
(47,167 |
) |
|
|
(458,269 |
) |
|
|
(216,876 |
) |
Net loss
attributable to common stockholders
|
|
$ |
(147,272 |
) |
|
$ |
(700,749 |
) |
|
$ |
(3,338,914 |
) |
|
$ |
(1,198,571 |
) |
Basic and
Diluted Loss per Common Share
|
|
$ |
(0.00 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.01 |
) |
|
$ |
(0.02 |
) |
Weighted
Average Number of Common Shares Outstanding
|
|
|
1,113,460,014 |
|
|
$ |
68,289,970 |
|
|
$ |
656,347,824 |
|
|
$ |
67,885,849 |
|
The accompanying notes are an integral part of these condensed
consolidated interim financial statements.
IGEN NETWORKS CORP.
Condensed Consolidated Statements of Redeemable Convertible
Preferred Stock and Stockholders’ Deficit
(Unaudited - Expressed in U.S. dollars)
|
|
Redeemable Series
A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
Convertible
Preferred
Stock
|
|
|
Series B
Preferred
Stock
|
|
|
Common
Stock
|
|
|
Additional
Paid In
|
|
|
Accumulated
|
|
|
Stockholders'
Equity
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
(Deficit)
|
|
Balance, December 31, 2019
|
|
|
160,600 |
|
|
$ |
31,927 |
|
|
|
- |
|
|
$ |
- |
|
|
|
74,242,196 |
|
|
$ |
74,242 |
|
|
$ |
10,697,216 |
|
|
$ |
(11,630,660 |
) |
|
$ |
(859,202 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Series A preferred stock for cash, net of
costs and discounts
|
|
|
47,300 |
|
|
|
1,608 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Series B preferred stock
|
|
|
- |
|
|
|
- |
|
|
|
1,000,000 |
|
|
|
1,000 |
|
|
|
- |
|
|
|
- |
|
|
|
276,543 |
|
|
|
- |
|
|
|
277,543 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Series A preferred shares to common
stock
|
|
|
(107,700 |
) |
|
|
(21,411 |
) |
|
|
- |
|
|
|
- |
|
|
|
81,700,258 |
|
|
|
81,700 |
|
|
|
103,693 |
|
|
|
(91,029 |
) |
|
|
94,364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued dividends on Series A preferred
stock
|
|
|
- |
|
|
|
1,742 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,742 |
) |
|
|
(1,742 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of common stock issued for cash
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
26,750,000 |
|
|
|
26,750 |
|
|
|
124,500 |
|
|
|
- |
|
|
|
151,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of common stock issued for conversion of
convertible note, including fees
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
95,216,504 |
|
|
|
95,217 |
|
|
|
175,753 |
|
|
|
- |
|
|
|
270,970 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
14,906 |
|
|
|
- |
|
|
|
14,906 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(859,173 |
) |
|
|
(859,173 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, March 31, 2020
|
|
|
100,200 |
|
|
|
13,866 |
|
|
|
1,000,000 |
|
|
|
1,000 |
|
|
|
277,908,958 |
|
|
|
277,909 |
|
|
|
11,392,611 |
|
|
|
(12,582,604 |
) |
|
|
(911,084 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Series A preferred stock for cash, net of
costs and discounts
|
|
|
100,100 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(156,472 |
) |
|
|
(156,472 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Series A preferred shares to common
stock
|
|
|
(40,500 |
) |
|
|
(10,115 |
) |
|
|
- |
|
|
|
- |
|
|
|
117,506,731 |
|
|
|
117,507 |
|
|
|
37,230 |
|
|
|
(25,650 |
) |
|
|
129,087 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued dividends on Series A preferred
stock
|
|
|
- |
|
|
|
63,554 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(63,554 |
) |
|
|
(63,554 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of common stock issued for conversion of
convertible note, including fees
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
524,841,289 |
|
|
|
524,841 |
|
|
|
738,152 |
|
|
|
- |
|
|
|
1,262,993 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cashless exercise of warrant
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
62,579,483 |
|
|
|
62,579 |
|
|
|
(62,579 |
) |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for conversion of
payables
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
26,828,800 |
|
|
|
26,829 |
|
|
|
40,243 |
|
|
|
- |
|
|
|
67,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase in value of warrants
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
370,726 |
|
|
|
(370,726 |
) |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,623,296 |
) |
|
|
(1,623,296 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, June 30, 2020
|
|
|
159,800 |
|
|
|
67,305 |
|
|
|
1,000,000 |
|
|
|
1,000 |
|
|
|
1,009,665,261 |
|
|
|
1,009,665 |
|
|
|
12,516,383 |
|
|
|
(14,822,302 |
) |
|
|
(1,295,254 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Series A preferred stock for cash, net of
costs and discounts
|
|
|
105,600 |
|
|
|
14,428 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(106,416 |
) |
|
|
(106,416 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Series A preferred shares to common
stock
|
|
|
(47,300 |
) |
|
|
(60,418 |
) |
|
|
- |
|
|
|
- |
|
|
|
43,305,496 |
|
|
|
45,306 |
|
|
|
108,891 |
|
|
|
718 |
|
|
|
154,915 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued dividends on Series A preferred
stock
|
|
|
- |
|
|
|
14,124 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(14,124 |
) |
|
|
(14,124 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of common stock issued for conversion of
convertible note, including fees
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
38,964,105 |
|
|
|
38,964 |
|
|
|
321,636 |
|
|
|
- |
|
|
|
360,600 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cashless exercise of warrant
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
42,459,207 |
|
|
|
42,459 |
|
|
|
(42,459 |
) |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock for commitment fee on
equity line
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
8,000,000 |
|
|
|
8,000 |
|
|
|
(8,000 |
) |
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(27,450 |
) |
|
|
(27,450 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2020
|
|
|
205,700 |
|
|
$ |
35,439 |
|
|
|
1,000,000 |
|
|
$ |
1,000 |
|
|
|
1,144,394,069 |
|
|
$ |
1,144,394 |
|
|
$ |
12,896,451 |
|
|
$ |
(14,969,574 |
) |
|
$ |
(927,729 |
) |
|
|
Redeemable Series
A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
Convertible
Preferred
Stock
|
|
|
Series B
Preferred
Stock
|
|
|
Common
Stock
|
|
|
Additional
Paid In
|
|
|
Accumulated
|
|
|
Stockholders'
Equity
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit
|
|
|
(Deficit)
|
|
Balance, December 31, 2018
|
|
|
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
- |
|
|
|
66,714,970 |
|
|
$ |
66,715 |
|
|
$ |
10,426,245 |
|
|
$ |
(11,049,499 |
) |
|
$ |
(556,539 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of common stock issued for cash
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,500,000 |
|
|
|
1,500 |
|
|
|
58,500 |
|
|
|
- |
|
|
|
60,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(196,507 |
) |
|
|
(196,507 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, March 31, 2019
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
68,214,970 |
|
|
|
68,215 |
|
|
|
10,484,745 |
|
|
|
(11,246,006 |
) |
|
|
(693,046 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Series A preferred stock issued for cash,
net of costs and discounts
|
|
|
144,300 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued dividends on Series A preferred
stock
|
|
|
|
|
|
|
1,642 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(1,642 |
) |
|
|
(1,642 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividends on Series A preferred
stock
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(168,067 |
) |
|
|
(168,067 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
15,000 |
|
|
|
- |
|
|
|
15,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(131,616 |
) |
|
|
(131,616 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, June 30, 2019
|
|
|
144,300 |
|
|
|
1,642 |
|
|
|
- |
|
|
|
- |
|
|
|
68,214,970 |
|
|
|
68,215 |
|
|
|
10,499,745 |
|
|
|
(11,547,331 |
) |
|
|
(979,371 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares of Series A preferred stock issued for cash,
net of costs and discounts
|
|
|
58,300 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued dividends on Series A preferred
stock
|
|
|
|
|
|
|
2,891 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(2,891 |
) |
|
|
(2,891 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividends on Series A preferred
stock
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(47,167 |
) |
|
|
(47,167 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
150,000 |
|
|
|
150 |
|
|
|
20,850 |
|
|
|
- |
|
|
|
21,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
loss
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(653,572 |
) |
|
|
(653,582 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, September 30, 2019
|
|
|
202,600 |
|
|
$ |
4,533 |
|
|
|
- |
|
|
$ |
- |
|
|
|
68,364,970 |
|
|
$ |
68,365 |
|
|
$ |
10,520,595 |
|
|
$ |
(12,250,961 |
) |
|
$ |
(1,662,011 |
) |
The accompanying notes are an integral part of these condensed
consolidated interim financial statements.
IGEN NETWORKS CORP.
Condensed Consolidated Interim Statements of Cash
Flows
(Unaudited - Expressed in U.S. dollars)
|
|
Nine
Months Ended
September 30,
|
|
|
|
2020
|
|
|
2019
|
|
Cash Flows from Operating Activities
|
|
|
|
|
|
|
Net
loss
|
|
$ |
(2,509,919 |
) |
|
$ |
(981,695 |
) |
Adjustments
to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
Accretion of discounts on convertible debentures
|
|
|
119,897 |
|
|
|
482,579 |
|
Change in fair value of derivative liabilities
|
|
|
1,082,407 |
|
|
|
(83,765 |
) |
Interest charge for derivative liabilities in excess of face amount
of debt
|
|
|
164,310 |
|
|
|
- |
|
Loss on extinguishment of debt
|
|
|
303,100 |
|
|
|
- |
|
Shares issued for services
|
|
|
- |
|
|
|
6,000 |
|
Stock-based compensation
|
|
|
292,449 |
|
|
|
49,500 |
|
Changes in
operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
and other receivables
|
|
|
17,236 |
|
|
|
(12,542 |
) |
Inventory
|
|
|
(7,329 |
) |
|
|
15,800 |
|
Prepaid
expenses and deposits
|
|
|
- |
|
|
|
4,484 |
|
Accounts
payable and accrued liabilities
|
|
|
50,155 |
|
|
|
109,814 |
|
Deferred
revenue
|
|
|
(117,655 |
) |
|
|
(101,381 |
) |
Net Cash
Used in Operating Activities
|
|
|
(605,349 |
) |
|
|
(511,206 |
) |
Cash Flows from Financing Activities
|
|
|
|
|
|
|
|
|
Repayment
of notes payable and convertible debentures
|
|
|
(50,000 |
) |
|
|
- |
|
Proceeds
from issuance of common stock
|
|
|
151,250 |
|
|
|
60,000 |
|
Proceeds
from notes payable and convertible debentures, net
|
|
|
298,449 |
|
|
|
253,250 |
|
Proceeds
from issuance of preferred stock, net
|
|
|
229,570 |
|
|
|
178,000 |
|
Net Cash
Provided by Financing Activities
|
|
|
629,269 |
|
|
|
491,250 |
|
|
|
|
|
|
|
|
|
|
Change in
Cash
|
|
|
23,920 |
|
|
|
(19,956 |
) |
Cash,
Beginning of Period
|
|
|
- |
|
|
|
56,823 |
|
Cash, End of Period
|
|
$ |
23,920 |
|
|
$ |
36,867 |
|
Non-cash
Investing and Financing Activities:
|
|
|
|
|
|
|
|
|
Conversion
of notes payable and accrued interest:
|
|
|
|
|
|
|
|
|
Fair value of common shares issued
|
|
$ |
1,894,562 |
|
|
$ |
- |
|
Derecognition of notes payable and accrued interest
|
|
$ |
(372,454 |
) |
|
$ |
- |
|
Derecognition of unamortized discount
|
|
$ |
229,322 |
|
|
$ |
- |
|
Derecognition of derivative liabilities
|
|
$ |
(1,448,326 |
) |
|
$ |
- |
|
Conversion
of preferred stock
|
|
|
|
|
|
|
|
|
Fair value of common shares issued
|
|
$ |
494,327 |
|
|
$ |
- |
|
Derecognition of preferred stock
|
|
$ |
(272,221 |
) |
|
$ |
- |
|
Derecognition of unamortized discount
|
|
$ |
163,326 |
|
|
$ |
- |
|
Derecognition of derivative liabilities
|
|
$ |
(286,782 |
) |
|
$ |
- |
|
Deemed dividend
|
|
$ |
(87,897 |
) |
|
$ |
- |
|
Discount
related to issuance of preferred stock
|
|
$ |
213,534 |
|
|
$ |
175,000 |
|
Deemed
dividends on preferred stock (excluding conversions)
|
|
$ |
(262,901 |
) |
|
$ |
(219,767 |
) |
Cashless
exercise of warrants
|
|
$ |
105,038 |
|
|
$ |
- |
|
Original
issue discount on convertible debt
|
|
$ |
- |
|
|
$ |
33,500 |
|
Increase in
value of warrants
|
|
$ |
370,726 |
|
|
$ |
- |
|
Conversion
of accrued liabilities with issuance of common stock
|
|
$ |
67,073 |
|
|
$ |
- |
|
Issuance of
common shares for commitment fee on equity line
|
|
$ |
8,000 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
Discount
for issuance of convertible debt
|
|
$ |
50,000 |
|
|
$ |
- |
|
Reclassification of security deposit to accounts payable
|
|
$ |
4,013 |
|
|
$ |
- |
|
The accompanying notes are an integral part of these condensed
consolidated interim financial statements.
IGEN NETWORKS CORP.
Notes to the Condensed Consolidated Interim Financial
Statements
September 30, 2020
(Unaudited - Expressed in U.S. dollars)
1. Organization and Description of
Business
IGEN Networks Corp. (“IGEN”, the “Company”, “we”, “our”) was
incorporated in the State of Nevada on November 14, 2006, under the
name of Nurse Solutions Inc. On September 19, 2008, the Company
changed its name to Sync2 Entertainment Corporation and traded
under the symbol SYTO. On September 15, 2008, the Company became a
reporting issuer in British Columbia, Canada. On May 26, 2009, the
Company changed its name to IGEN Networks Corp. On March 25, 2015,
the Company was listed on the Canadian Securities Exchange (CSE)
under the trading symbol IGN and the Company became a reporting
Venture Issuer in British Columbia and Ontario, Canada.
The Company’s principal business is the development and marketing
of software services for the automotive industry. The Company works
with wireless carriers, hardware suppliers and software developers
to provide direct and secure access to information on the vehicle
and the driver’s behavior. The software services are delivered from
the AWS Cloud to the consumer and their families over the wireless
networks and accessed from any mobile or desktop device. The
software services are marketed to automotive dealers, financial
institutions, and direct-to-consumer through various commercial and
consumer brands.
Going Concern
The accompanying condensed consolidated financial statements have
been prepared assuming that the Company will continue as a going
concern. The Company has experienced recurring losses from
operations, has negative operating cash flows since inception, has
a working capital deficit of $1,359,270 and an accumulated deficit
of $14,969,574 as of September 30, 2020, and is dependent on its
ability to raise capital from stockholders or other sources to
sustain operations. These factors raise substantial doubt about the
Company’s ability to continue as a going concern. Ultimately, the
Company plans to achieve profitable operations through the increase
in revenue base and successfully grow its operations organically or
through acquisitions. The condensed consolidated financial
statements do not include any adjustments that might result from
the outcome of these uncertainties.
2. Summary of Significant Accounting
Policies
Basis of Presentation and
Consolidation
These consolidated financial statements and related notes include
the records of the Company and the Company’s wholly-owned
subsidiary, Nimbo Tracking LLC which is formed in the USA.
The condensed consolidated balance sheet as of December 31, 2019,
which has been derived from audited consolidated financial
statements, and these unaudited condensed consolidated financial
statements have been prepared by management in accordance with
accounting principles generally accepted in the United States
(“U.S. GAAP”), and include all assets, liabilities, revenues and
expenses of the Company and its wholly-owned subsidiary. All
material intercompany transactions and balances have been
eliminated. These interim unaudited condensed consolidated
financial statements and notes thereto should be read in
conjunction with Management’s Discussion and Analysis of Financial
Condition and Results of Operations and the audited consolidated
financial statements and notes thereto included in our Annual
Report on Form 10-K for the year ended December 31, 2019. Certain
information required by U.S. GAAP has been condensed or omitted in
accordance with the rules and regulations of the U.S. Securities
and Exchange Commission (“SEC”). The results for the three and nine
month periods ended September 30, 2020 are not necessarily
indicative of the results to be expected for the entire fiscal year
ending December 31, 2020, or for any future period.
Use of Estimates
The preparation of these condensed consolidated financial
statements in conformity with U.S. GAAP requires management to make
estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and
liabilities at the date of the consolidated financial statements,
and the reported amounts of revenues and expenses during the
reporting period. The Company regularly evaluates estimates and
assumptions related to allowance for doubtful accounts, valuation
of inventory, the useful life and recoverability of equipment,
impairment of goodwill, valuation of notes payable and convertible
debentures, fair value of stock-based compensation and derivative
liabilities, and deferred income tax asset valuation allowances.
The Company bases its estimates and assumptions on current facts,
historical experience and various other factors that it believes to
be reasonable under the circumstances, the results of which form
the basis for making judgments about the carrying values of assets
and liabilities and the accrual of costs and expenses that are not
readily apparent from other sources. The actual results experienced
by the Company may differ materially and adversely from the
Company’s estimates. To the extent there are material differences
between the estimates and the actual results, future results of
operations will be affected.
Cash and Cash Equivalents
The Company considers all highly liquid instruments purchased with
an original maturity of three months or less at the time of
acquisition to be cash equivalents.
Accounts Receivable
Accounts receivable are recognized and carried at the original
invoice amount less an allowance for expected uncollectible
amounts. Inherent in the assessment of the allowance for doubtful
accounts are certain judgments and estimates including, among
others, the customer’s willingness or ability to pay, the Company’s
compliance with customer invoicing requirements, the effect of
general economic conditions and the ongoing relationship with the
customer. Accounts with outstanding balances longer than the
payment terms are considered past due. We do not charge interest on
past due balances. The Company writes off trade receivables when
all reasonable collection efforts have been exhausted. Bad debt
expense is reflected as a component of general and administrative
expenses in the consolidated statements of operations. As of
September 30, 2020 and December 31, 2019, the allowance for
doubtful accounts was approximately $29,000 and $21,000,
respectively.
Inventory
Inventory consists of vehicle tracking and recovery devices and is
comprised entirely of finished goods that can be resold. Inventory
is stated at the lower of cost or net realizable value. Cost is
determined on a first-in, first-out (FIFO) basis. Net realizable
value is the estimated selling price in the ordinary course of
business, less estimated costs of completion and selling costs.
There was no provision for inventory impairment recorded as of
September 30, 2020 and December 31, 2019.
Equipment
Office equipment, computer equipment, and software are recorded at
cost. Depreciation is provided annually at rates and methods over
their estimated useful lives. Management reviews the estimates of
useful lives of the assets every year and adjusts them on
prospective basis, if needed. All equipment was fully depreciated
as of December 31, 2019. For purposes of computing depreciation,
the method of depreciating equipment is as follows:
Computer
equipment
|
3 years
straight-line
|
Office
equipment
|
5 years
straight-line
|
Software
|
3 years
straight-line
|
Goodwill
Goodwill represents the excess of the acquisition price over the
fair value of identifiable net assets acquired. Goodwill is
allocated at the date of the business combination. Goodwill is not
amortized, but is tested for impairment annually on December 31 of
each year or more frequently if events or changes in circumstances
indicate the asset may be impaired. These events and circumstances
may include a significant change in legal factors or in the
business climate, a significant decline in the Company’s share
price, an adverse action of assessment by a regulator,
unanticipated competition, a loss of key personnel, significant
disposal activity and the testing of recoverability for a
significant asset group.
Goodwill impairment is measured as the amount by which a reporting
unit’s carrying value exceeds its fair value.
The Company has only one reporting unit. Therefore, all of the
Company’s goodwill relates to that reporting unit, and at September
30, 2020 and December 31, 2019, the carrying value for that
reporting unit is negative.
Impairment of Long-lived Assets
The Company reviews long-lived assets, such as equipment, for
impairment whenever events or changes in the circumstances indicate
that the carrying value may not be recoverable. If the total of the
estimated undiscounted future cash flows is less than the carrying
value of the asset, an impairment loss is recognized for the excess
of the carrying value over the fair value of the asset during the
year the impairment occurs.
Financial Instruments
In accordance with Financial Accounting Standard Board (“FASB”)
Accounting Standards Codification (“ASC”) 820, “Fair Value
Measurements and Disclosures,” the Company is to maximize the use
of observable inputs and minimize the use of unobservable inputs
when measuring fair value. ASC 820 establishes a fair value
hierarchy based on the level of independent, objective evidence
surrounding the inputs used to measure fair value. A financial
instrument’s categorization within the fair value hierarchy is
based upon the lowest level of input that is significant to the
fair value measurement. ASC 820 prioritizes the inputs into three
levels that may be used to measure fair value:
Level 1
Level 1 applies to assets or liabilities for which there are quoted
prices in active markets for identical assets or liabilities.
Level 2
Level 2 applies to assets or liabilities for which there are inputs
other than quoted prices that are observable for the asset or
liability such as quoted prices for similar assets or liabilities
in active markets; quoted prices for identical assets or
liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in
which significant inputs are observable or can be derived
principally from, or corroborated by, observable market data.
Level 3
Level 3 applies to assets or liabilities for which there are
unobservable inputs to the valuation methodology that are
significant to the measurement of the fair value of the assets or
liabilities.
See Note 4 for fair value measurement information related to the
Company’s derivative liabilities.
The fair values of cash and cash equivalents, accounts and other
receivables, restricted cash, and accounts payable and accrued
liabilities, approximate their carrying values due to the immediate
or short-term maturity of these financial instruments. Foreign
currency transactions are primarily undertaken in Canadian dollars.
The fair value of cash and cash equivalents is determined based on
“Level 1” inputs and the fair value of derivative liabilities is
determined based on “Level 3” inputs. The recorded values of notes
payable, approximate their current fair values because of their
nature and respective maturity dates or durations. The financial
risk is the risk to the Company’s operations that arise from
fluctuations in foreign exchange rates and the degree of volatility
to these rates. Currently, the Company does not use derivative
instruments to reduce its exposure to foreign currency risk.
Financial instruments that potentially subject the Company to
concentrations of credit risk consists of cash. The Company places
its cash and cash equivalents in what it believes to be
credit-worthy financial institutions.
Revenue Recognition and Deferred
Revenue
We recognize revenue in accordance with ASC 606, “Revenue from
Contracts with Customers”, using the five-step model, including (1)
identify the contract with the customer, (2) identify the
performance obligations in the contract, (3) determine the
transaction price, (4) allocate the transaction price to the
performance obligations in the contract, and (5) recognize revenue
in accordance with U.S. GAAP. Title and risk of loss generally pass
to our customers upon delivery, as we have insurance for lost
shipments. In limited circumstances where either title or risk of
loss pass upon destination or acceptance or when collection is not
reasonably assured, we defer revenue recognition until such events
occur. We derive substantially all our revenues from the sale of
products and services combined into one performance obligation.
Product revenue includes the shipment of product according to the
agreement with our customers. Service revenue include vehicle
tracking services and customer support (technical support),
installations and consulting. A contract usually includes both
product and services. For these contracts, the Company accounts for
individual performance obligations separately if they are distinct.
Performance obligations include, but are not limited to, pass-thru
harnesses and vehicle tracking services. Almost all of our revenues
are derived from customers located in United States of America in
the auto industry. The transaction price is allocated to the
separate performance obligations on a relative standalone selling
price basis. Standalone selling prices are typically estimated
based on observable transactions when these services are not sold
on a standalone basis. At contract inception, an assessment of the
goods and services promised in the contracts with customers is
performed and a performance obligation is identified for each
distinct promise to transfer to the customer a good or service (or
bundle of goods or services). To identify the performance
obligations, the Company considers all of the goods or services
promised in the contract regardless of whether they are explicitly
stated or are implied by customary business practices. Revenue is
recognized when our performance obligation has been met. The
Company considers control to have transferred upon delivery because
the Company has a present right to payment at that time, the
Company has transferred use of the asset, and the customer is able
to direct the use of, and obtain substantially all of the remaining
benefits from, the asset. For arrangements under which the Company
provides vehicle tracking services, the Company satisfies its
performance obligations as those services are performed whereby the
customer simultaneously receives and consumes the benefits of such
services under the agreement. Revenues are recognized net of any
taxes collected from customers, which are subsequently remitted to
governmental authorities.
The Company provides product warranties with varying lengths of
time and terms. The product warranties are considered to be
assurance-type in nature and do not cover anything beyond ensuring
that the product is functioning as intended. Based on the guidance
in ASC 606, assurance-type warranties do not represent separate
performance obligations. The Company has historically experienced a
low rate of product returns under the warranty program.
Management assesses the business environment, customers’ financial
condition, historical collection experience, accounts receivable
aging, and customer disputes to determine whether collectability is
reasonably assured. If collectability is not reasonably assured at
the time of sale, the Company does not recognize revenue until
collection occurs.
Revenue relating to the sale of service fees on its vehicle
tracking and recovery services is recognized over the life of the
contact. The service renewal fees are offered in terms ranging from
12 to 36 months and are generally payable upon delivery of the
vehicle tracking devices or in full upon renewal.
Deferred revenues are recorded net of contract assets when cash
payments are received from customers in advance of the Company’s
performance. Contract assets represent the costs of the underlying
hardware to enable the Company to perform on its contracts with
customers and are amortized using the same method and term as
deferred revenues. As of September 30, 2020 and December 31, 2019,
deferred revenues, net of contract assets totaled $144,810 and
$262,465, respectively, and contract assets totaled $52,206 and
$143,088, respectively. Any revenue that has been deferred and is
expected to be recognized beyond one year is classified as deferred
revenue, net of current portion.
During the nine months ended September 30, 2020, the Company
recorded additions to deferred revenues of $71,625 and recognized
total revenues of $280,161 through the amortization of deferred
revenues. During the nine months ended September 30, 2020, the
Company recognized revenues of $253,241 related to deferred
revenues outstanding as of December 31, 2019 as the services were
performed.
Financing Costs and Debt Discount
Financing costs and debt discounts are recorded net of notes
payable and convertible debentures in the consolidated balance
sheets. Amortization of financing costs and the debt discounts is
calculated using the effective interest method over the term of the
debt and is recorded as interest expense in the consolidated
statement of operations.
Income Taxes
Deferred income taxes are provided on the asset and liability
method whereby deferred income tax assets are recognized for
deductible temporary differences and operating loss and tax credit
carry-forwards and deferred tax liabilities are recognized for
taxable temporary differences. Temporary differences are the
differences between the reported amounts of assets and liabilities
and their tax bases. Deferred income tax assets are reduced by a
valuation allowance when, in the opinion of management, it is more
likely than not that some portion or all of the deferred income tax
assets will not be realized. Deferred income tax assets and
liabilities are adjusted for the effects of changes in tax laws and
rates on the date of enactment.
Stock-based Compensation
The Company accounts for stock-based payments in accordance with
stock-based payment accounting guidance which requires all
stock-based payments to be recognized based upon their fair values.
The fair value of stock-based awards is estimated at the grant date
using the Black-Scholes Option Pricing Model and the portion that
is ultimately expected to vest is recognized as compensation cost
over the requisite service period. The determination of fair value
using the Black-Scholes Option Pricing Model is affected by the
Company’s stock price as well as assumptions regarding a number of
complex and subjective variables, including expected stock price
volatility, risk-free interest rate, expected dividends and
projected employee stock option exercise behaviors. The Company
accounts for forfeitures of unvested awards as they occur.
Derivative Financial Instruments
The Company classifies as equity any contracts that require
physical settlement or net-share settlement or provide us a choice
of net cash settlement or settlement in our own shares (physical
settlement or net-share settlement) provided that such contracts
are indexed to our own stock as defined in ASC Topic 815-40
"Contracts in Entity's Own Equity." The Company classifies as
assets or liabilities any contracts that require net-cash
settlement including a requirement to net cash settle the contract
if an event occurs and if that event is outside our control or give
the counterparty a choice of net-cash settlement or settlement in
shares. The Company assesses classification of its free-standing
derivatives at each reporting date to determine whether a change in
classification between assets and liabilities is required.
Loss Per Share
Basic earnings (loss) per share are computed by dividing net income
(loss) available to common shareholders (numerator) by the weighted
average number of shares outstanding (denominator) during the
period. Diluted earnings per share give effect to all dilutive
potential common shares outstanding during the period including
stock options and warrants, using the treasury stock method, and
convertible debentures, using the if-converted method. In computing
diluted earnings (loss) per share, the average stock price for the
period is used in determining the number of shares assumed to be
purchased from the exercise of stock options or warrants. Diluted
earnings (loss) per share exclude all potentially issuable shares
if their effect is anti-dilutive. Because the effect of conversion
of the Company’s dilutive securities is anti-dilutive, diluted loss
per share is the same as basic loss per share for the periods
presented. As of September 30, 2020 and 2019, the Company has
216,410,882 and 8,089,673 potentially dilutive shares outstanding,
respectively.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, “Debt -
Debt with Conversion and Other Options (Subtopic 470-20) and
Derivatives and Hedging - Contracts in Entity’s Own Equity
(Subtopic 815 - 40)” (“ASU 2020-06”).
ASU 2020-06 simplifies the accounting for certain
financial instruments with characteristics of liabilities and
equity, including convertible instruments and contracts on an
entity’s own equity. The ASU is part of the FASB’s simplification
initiative, which aims to reduce unnecessary complexity in U.S.
GAAP. The ASU’s amendments are effective for fiscal years beginning
after December 15, 2023, and interim periods within those fiscal
years. The Company is currently evaluating the impact
ASU 2020-06 will have on its financial statements.
3. Convertible Debentures and Notes
Payable
On May 17, 2019, the Company entered into a Convertible Promissory
Note (“Promissory Note”) with Crown Bridge Partners, LLC (the
“Holder”) for a total principal amount of up to $150,000 with cash
proceeds of up to $124,500, resulting in an original issue discount
of up to $25,500. The Promissory Note bears interest at 7% per
annum (with the understanding that the first 12 months of interest
of each tranche will be guaranteed). The maturity date is 18 months
from the effective date of each payment.
The Conversion Price, as defined in the agreement, is the lesser of
(i) the lowest Trading Price (as defined below) during the previous
25 trading day period ending on the latest complete trading day
prior to the date of this Promissory Note or (ii) the Variable
Conversion Price (as defined below). The Variable Conversion Price
means the lowest one Trading Price (as defined below) for the
common stock during the 25 Trading Day period ending on the last
complete Trading Day prior to the Conversion Date. Trading Price
means, for any security as of any date, the lesser of the (i)
lowest traded price and (ii) lowest closing bid price. Based on the
Company’s examination of the conversion feature and the relative
accounting guidance, the Company has determined that the conversion
feature should be treated as a derivative liability for accounting
purposes.
Additionally, if at any time while the Promissory Note is
outstanding, the Conversion Price is equal to or lower than $0.025,
then an additional $10,000 will be automatically added to the
principal balance of each tranche funded under the Note. During the
quarter ended June 30, 2019, $10,000 was added to the principal
balance for the first tranche.
In connection with the Promissory Note, the Company also entered
into a Securities Purchase Agreement with the Holder which states
that the Company will also issue to the Holder a warrant to
purchase an amount of shares of its common stock equal to 50% of
the face value of each respective tranche divided by $0.10 (for
illustrative purposes, the first tranche face value is equal to
$50,000, which resulted in the issuance of a warrant to purchase
250,000 shares of the Company’s common stock).
Per the terms of the Common Stock Purchase Warrant agreement, on
May 17, 2019, the Company issued a warrant to purchase 250,000
shares of common stock with an Exercise Price of $0.10 subject to
adjustment (standard anti-dilution features). The agreement
contains a down-round provision that automatically resets the
exercise price of the warrant to a new exercise price that is equal
to the per share price of common stock subsequently issued
(including conversions of debt and preferred stock). Upon the
lowing of the exercise price, the number of warrants will be
increased such that the total proceeds upon exercise is the same
amount (see Note 7). If the Market Price of one shares of
common stock is greater than the Exercise Price, the Holder may
elect to receive Warrant Shares pursuant to cashless exercise, in
lieu of cash exercise, per a defined formula in the agreement.
During the quarter ended June 30, 2019, the Company received
$40,000 in net cash proceeds, after paying $1,500 of direct funding
costs. The related principal amount due for the first tranche
(“First Tranche”) was $50,000. For the first tranche, using the
Binomial Lattice Model, the Company computed the estimated fair
value of the embedded conversion feature to be $100,000 and
recorded a related derivative liability. Related to the derivative
liability, the bonus interest, and the direct financing costs, the
Company recorded a full debt discount of $60,000 for the Promissory
Note, which will be amortized to interest expense over the term of
the Promissory Note using the effective interest method and an
additional $50,000 directly to interest expense.
On December 9, 2019, the Holder converted a portion of the
Promissory Note into shares of common stock. The Holder received
300,000 shares of common stock for the conversion of principal,
accrued interest, and fees totaling $7,165.
During the quarter ended September 30, 2019, the Company received
an aggregate of $213,250 in net cash proceeds, after paying $6,750
of direct funding costs, from three note holders under the same
terms as the Promissory Note. The related principal amount due for
the convertible debt instruments entered into during the quarter
ended September 30, 2019 was $255,000. Using the Binomial Lattice
Model, the Company computed the estimated fair value of the
embedded conversion features to be approximately $354,000 and
recorded the related derivative liabilities. Related to the
derivative liabilities, the bonus interest, and the direct
financing costs, the Company recorded full debt discounts totaling
approximately $255,000 for the notes which will be amortized to
interest expense over the term of the notes using the effective
interest method and an additional approximately $106,000 directly
to interest expense. As the Conversion Price fell below $0.025 per
share, during the quarter ended September 30, 2019, $10,000 was
added to the principal balance on one of the notes (per the terms
of that note).
Related to the notes issued during the quarter ended September 30,
2019, the Company issued warrants to purchase a total of 525,000
shares of common stock with an Exercise Price of $0.10 subject to
adjustment (standard anti-dilution features). If the Market Price
of one shares of common stock is greater than the Exercise Price,
the Holder may elect to receive Warrant Shares pursuant to cashless
exercise, in lieu of cash exercise, per a defined formula in the
agreement.
On October 1, 2019, the Company received $37,500 in net cash
proceeds from a note holder under the same terms as the Promissory
Note. The related principal amount due for the convertible debt
instrument was $44,000. In connection with the note, the Company
issued 100,000 shares of common stock, which were valued at the
market price on the date of issuance of $0.05 per share. Using the
Binomial Lattice Model, the Company computed the estimated fair
value of the embedded conversion feature to be approximately
$29,000 and recorded a related derivative liability. Related to the
derivative liability, the shares issued, the bonus interest, and
the direct financing costs, the Company recorded a debt discount
totaling $41,000 for the note, which will be amortized to interest
expense over the term of the note using the effective interest
method.
On June 19, 2020, the Company received $19,250 in net cash proceeds
from a note holder under the same terms as the Promissory Note. The
related principal amount due for the convertible debt instrument
was $25,000. Using the Binomial Lattice Model, the Company computed
the estimated fair value of the embedded conversion feature to be
approximately $142,000 and recorded a related derivative liability
for that amount and a charge to interest expense of approximately
$122,000. Related to the derivative liability, the shares issued,
the bonus interest, and the direct financing costs, the Company
recorded a debt discount totaling $25,000 for the note, which is
being amortized to interest expense over the term of the note using
the effective interest method.
On July 10, 2020, the Company received $19,250 in net cash proceeds
from a note holder under the same terms as the Promissory Note. The
related principal amount due for the convertible debt instrument
was $25,000. Using the Binomial Lattice Model, the Company computed
the estimated fair value of the embedded conversion feature to be
approximately $61,000 and recorded a related derivative liability
for that amount and a charge to interest expense of approximately
$42,000. Related to the derivative liability, the shares issued,
the bonus interest, and the direct financing costs, the Company
recorded a debt discount totaling $25,000 for the note, which is
being amortized to interest expense over the term of the note using
the effective interest method.
During the nine months ended September 30, 2020, the holders of the
convertible notes converted a total of $379,203 of principal,
interest and fees for a total of 659,021,898 shares of common
stock. Related to these conversions during the nine months ended
September 30, 2020, the Company recorded a reduction of the
associated derivative liability for the conversion features of
$1,448,326 and a reduction of the debt discount of $229,322 as
components of the loss on settlement of debt. During the nine
months ended September 30, 2020, the Company recorded $119,897 of
interest expense related to the amortization of the debt
discounts.
During the three months ended March 31, 2020 the Company borrowed
$50,000 from a shareholder under the terms of a note payable
bearing interest of 8% per annum. The note was repaid with interest
(totaling $922) during the three months ended March 31, 2020.
On May 4, 2020, the Company entered into a Paycheck Protection
Program (“PPP”) Loan with a principal amount of $59,949 through a
financial institution under the PPP administered by the SBA and
established as part of the CARES Act. The PPP Loan bears interest
at 1.0% per annum and matures on May 4, 2022 with the first six
months of interest and principal payments deferred. The amount
borrowed under the PPP Loan is guaranteed by the U.S. Small
Business Administration (“SBA”) and is eligible for forgiveness in
an amount equal to the sum of the eligible costs, including
payroll, benefits, rent and utilities, incurred by the Company
during the 24-week period beginning on the date the Company
received the proceeds. The PPP Loan contains customary events of
default, and the occurrence of an event of default may result in a
claim for the immediate repayment of all amounts outstanding under
the PPP Loan.
On July 7, 2020, the Company entered into a secured disaster loan
with the SBA with a principal amount of $150,000. The SBA loan
bears interest at 3.75% per annum and matures in July 2050. The
Company is required to make monthly principal and interest payments
of $731 beginning in July 2021. The Company is obligated to make
the following principal payments for the years ended December 31:
2021 - $1,241; 2022 - $3,058; 2023 - $3,175; 2024 - $3,296; 2025 -
$3,422; and $135,808 thereafter.
4. Derivative Liabilities
During the nine months ended September 30, 2020 and during the year
ended December 31, 2019, the Company had outstanding convertible
debentures with variable exercise prices based on market rates (see
Note 3). During the nine month ended September 30, 2020 and during
year ended December 31, 2019, the Company also issued series A
preferred stock with variable exercise prices based on market rates
(see Note 6). The Company records the fair value of the conversion
features with variable exercise prices based on future market rates
in accordance with ASC 815. The fair value of the derivative
liabilities is revalued on each balance sheet date with
corresponding gains and losses recorded in the consolidated
statements of operations. The Company uses a multi-nominal lattice
model to fair value the derivative liabilities. The following
inputs and assumptions were used to value the conversion features
outstanding during the nine months ended September 30, 2020,
assuming no expected dividends:
|
|
September 30,
2020
|
Expected
volatility
|
|
|
271 - 322
|
%
|
Risk free
interest rate
|
|
|
0.3 -
1.41
|
%
|
Expected
life (in years)
|
|
|
0.5 - 1.5
|
|
The following table presents the Company’s embedded conversion
features of its convertible debt and preferred stock measured at
fair value on a recurring basis as of September 30, 2020.
|
|
Level 3
Carrying
Value as of
September 30,
2020
|
|
Derivative
liabilities:
|
|
|
|
Embedded
conversion feature - convertible debt
|
|
$ |
25,495 |
|
Embedded
conversion feature - preferred stock
|
|
|
77,131 |
|
|
|
$ |
102,626 |
|
The following table provides a reconciliation of the beginning and
ending balances for the Company’s derivative liabilities measured
at fair value using Level 3 inputs:
|
|
For
The
Nine
Months
Ended
September 30,
2020
|
|
Embedded
Conversion Features - Convertible Debt
|
|
|
|
Balances,
as of the beginning of the year
|
|
$ |
87,571 |
|
Derivative
liabilities recorded upon issuance of convertible debt
|
|
|
202,810 |
|
Derivative
liabilities derecognized upon debt conversion
|
|
|
(1,448,326 |
) |
Net changes
in fair value included in net loss
|
|
|
1,183,440 |
|
Ending
balance
|
|
$ |
25,495 |
|
|
|
|
|
|
Embedded
Conversion Features - Preferred Stock
|
|
|
|
|
Balances,
as of the beginning of the year
|
|
$ |
4,751 |
|
Derivative
liabilities recorded upon issuance of preferred stock
|
|
|
476,435 |
|
Derivative
liabilities derecognized upon preferred stock conversion
|
|
|
(286,782 |
) |
Net changes
in fair value included in net loss
|
|
|
(117,273 |
) |
Ending
balance
|
|
$ |
77,131 |
|
|
|
|
|
|
Total
ending balance
|
|
$ |
102,626 |
|
5. Related Party Transactions
(a)
|
During the
nine months ended September 30, 2020 and 2019, the Company incurred
approximately $106,000 and $106,000, respectively, in management
and consulting fees with an officer and an entity controlled by
him. As of September 30, 2020 and December 31, 2019, the Company
owed approximately $103,000 and $190,000, respectively, to
directors and officers and a company controlled by a director,
which is included in accounts payable and accrued liabilities. The
amounts owed are unsecured, non-interest bearing, and due on
demand.
|
|
|
(b)
|
During the
nine months ended September 30, 2020 and 2019, the Company incurred
approximately $28,000 and $92,000, respectively, in purchases of
hardware from a vendor controlled by a director of the Company. As
of September 30, 2020 and December 31, 2019, the amounts owed to
this related-party vendor were approximately $17,000 and $45,000
respectively.
|
(c)
|
During the
nine months ended September 30, 2020, the Company issued 26,828,800
shares of common stock for the conversion of $67,073 of accrued
expenses owed to the CEO and VP of Operations.
|
6. Redeemable Preferred Stock and
Stockholders’ Deficit
Preferred Stock
The Company is authorized to issue 10,000,000 shares of preferred
stock with a par value of $0.001 per share. The Company has
designated 1,250,000 of these shares as Series A Convertible
Preferred Stock and 2,000,000 of these shares as Series B Super
Voting Preferred Stock.
On April 9, 2019 and separately on June 11, 2019, the Company
entered into a Series A Preferred Stock Purchase Agreement with an
investor. On April 9, 2019, the Company issued 86,000 shares for
net proceeds of $75,000 (after deducting $3,000 of direct legal
costs) and on June 11, 2019, the Company issued 58,300 shares for
net proceeds of $50,000 (after $3,000 deduction of direct legal
costs).
On September 17, 2019, the Company entered into a Series A
Preferred Stock Purchase Agreement with an investor. The Company
issued 58,300 shares for net proceeds of $50,000 (after $3,000
deduction of direct legal costs).
On February 25, 2020, the Company entered into a Series A Preferred
Stock Purchase Agreement with an investor. The Company issued
47,300 shares for proceeds of $43,000.
During the quarter ended June 30, 2020, the Company entered into
two Series A Preferred Stock Purchase Agreements with an investor.
The Company issued 100,100 shares for proceeds of $91,000.
During the quarter ended September 30, 2020, the Company entered
into two Series A Preferred Stock Purchase Agreements with an
investor. The Company issued 105,600 shares for proceeds of $96,000.
Rights and Privileges of the Series A Preferred
Stock
|
☐
|
Voting - Series A Preferred Stock holders
have no voting rights
|
|
☐
|
Dividends - 8% cumulative dividend,
compounded daily, payable solely upon redemption, liquidation, or
conversion. (increases to 22% for an event of default)
|
|
☐
|
Redemption - Company has the right to
redeem the shares from the issuance date through 270 days following
the issuance date using the table noted in the Certificate of
Designations, Preferences, Rights and Limitations of Series A
Convertible Preferred Stock agreement. After 270 days, except for
the Mandatory Redemption, the Company does not have the right to
redeem the shares.
|
|
☐
|
Mandatory Redemption - 18 months after the
Issuance Date or upon the occurrence of an Event of Default, the
Company is required to redeem all of the shares of Series A
Preferred Stock of the Holder. The Company shall make a cash
payment in an amount equal to the total number of shares of Series
A Preferred Stock held by the Holder multiplied by the then current
Stated Value as adjusted (including but not limited to the addition
of any accrued unpaid dividends and the Default Adjustment
|
|
☐
|
Conversion - At any time after 6 months
following the Issuance Date, the Holder may convert all or any part
of the outstanding Series A Preferred Stock into shares of Common
Stock. The Variable Conversion Price is defined as 75% of the the
Market Price. The Market Price is defined as the average of the 3
lowest Trading Prices for the Common Stock during the 15 day
Trading Period ending on the last complete Trading Day prior to the
Conversion Date.
|
|
☐
|
Default Adjustments - Upon the occurrence
of any Event of Default, the Stated Value will be increased between
150% and 200%, depending on the Event of Default.
|
Based on the terms of the conversion feature, the Company could be
required to issue an infinite number of shares of common stock. As
such, the Company has determined the conversion feature to be a
derivative liability under relevant accounting guidance. The
Company estimated the fair value of the conversion feature using
the Binomial Lattice Model on the date of issuance, on the date of
each conversion notice, and remeasures the fair value at each
reporting period. During the nine months ended September 30, 2020,
the Company issued 253,000 shares of series A preferred stock for
proceeds of $229,570. Related to these issuances, the Company
recorded derivative liabilities of $476,435 and discounts to the
preferred stock of $213,534, which is being amortized to deemed
dividends over the redemption
period. Also related to these issuances the Company recorded deemed dividends of $262,888.
During 2019, holders converted 42,000 shares of Series A Preferred
stock into 2,977,226 shares of common stock at the Variable
Conversion Price as defined above, resulting in a loss on
extinguishment of $23,000.
During the nine months ended September 30, 2020, the holder of the
series A preferred stock converted 207,900 shares of series A
preferred stock and accrued dividends into 244,512,485 shares of
common stock. Related to these conversions during the nine months
ended September 30, 2020, the Company recorded a reduction of the
associated derivative liability for the conversion features of
$286,782 and a reduction of the preferred stock discount of
$163,326 and $87,897 of deemed dividend.
Rights and Privileges of the Series B Preferred
Stock
On February 10, 2020, the Company designated and subsequently
issued 1,000,000 shares of its newly formed Series B Super Voting
Preferred Stock. Each share of Series B preferred stock has voting
rights equal to 500 shares of common stock, is not entitled to
receive dividends, is not convertible into shares of common stock.
If the holder of the Series B preferred stock ceases to be a Board
Member, the Company will repurchase any Series B preferred stock
from the holder for a price of $0.001 per share. If the holder of
the Series B preferred stock proposes to transfer any shares of
Series B preferred stock, the Company will have 90 days to
repurchase the shares for a price of $0.001 per share. The grant
date fair value of the Series B preferred stock issued during the
three months ended March 31, 2020 was $277,543 and was recorded to
stock-based director compensation expense in the accompanying
condensed consolidated statement of operations.
Common Stock
2020
During the nine months ended September 30, 2020, the Company sold a
total of 26,750,000 shares of common stock for proceeds of
$151,250.
During the nine months ended September 30, 2020, the Company issued
a total of 903,534,383 shares of common stock for the conversion of
debt, accrued interest and fees, and the conversion of series A
preferred stock and accrued dividends.
During the nine months ended September 30, 2020, the Company issued
105,038,690 shares of common stock for the cashless exercise of
warrants.
During the nine months ended September 30, 2020, the Company issued
26,828,800 shares of common stock for the conversion of $67,072 of
accrued expenses owed to the CEO and VP of Operations.
On July 27, 2020, the Company entered into an Equity Purchase
Agreement with an investor. Per the terms of the agreement, the
investor will purchase up to $2,500,000 of the Company’s common
stock at a 20% discount to the market price or the valuation price
(as defined). The Company has the right, but not the obligation, to
direct the investor to purchase put shares of not less than $5,000
and not more than $175,000 or 200% of the average daily trading
value (as defined). During the nine months ended September 30,
2020, the Company issued 8,000,000 shares of common stock as a
commitment fee on an equity line of credit with an investor, which
was recorded as an offset to additional paid in capital in the
accompanying condensed consolidated financial statements.
2019
During the nine months ended September 30, 2019, the Company sold a
total of 1,500,000 shares of common stock for proceeds of
$60,000.
During the nine months ended September 30, 2019, the Company issued
150,000 shares of common stock for services valued at $6,000.
7. Share Purchase Warrants
The following table summarizes the continuity schedule of the
Company’s share purchase warrants:
|
|
Number of
warrants
|
|
|
Weighted
average
exercise
price
|
|
|
|
|
|
|
|
|
Balance,
December 31, 2019
|
|
|
4,527,614 |
|
|
|
0.18 |
|
Issued
|
|
|
- |
|
|
|
- |
|
Adjusted
for triggered down-round provisions
|
|
|
315,521,528 |
|
|
|
0.00 |
|
Exercised
|
|
|
(96,957,101 |
) |
|
|
0.00 |
|
Expired
|
|
|
(56,574,123 |
) |
|
|
0.00 |
|
Balance,
September 30, 2020
|
|
|
166,517,918 |
|
|
$ |
0.00 |
|
As of September 30, 2020, the following share purchase warrants
were outstanding:
Number of warrants outstanding
|
|
|
Exercise price
|
|
|
Expiration date
|
|
|
2,222,222
|
|
|
$ |
0.03 |
|
|
December 2,
2024
|
|
|
163,265,304 |
|
|
$ |
0.00 |
|
|
September
23, 2024
|
|
|
980,392 |
|
|
$ |
0.15 |
|
|
December 2,
2021
|
|
|
50,000 |
|
|
$ |
0.20 |
|
|
January 2,
2022
|
|
|
166,517,918 |
|
|
|
|
|
|
|
|
During the nine months ended September 30, 2020, the Company
recognized the triggering of the down-round provisions of certain
warrants associated with the convertible debt instruments issued in
2019. As a result, the reset exercise price increased the
number of warrant shares accordingly. As of September 30,
2020, the new exercise price for the warrants is $0.000245 per
share. Per the relevant accounting guidance, the Company
valued the warrants before and after each triggering event and
recorded the total increase in value as a deemed dividend to the
warrant holder with an offset to additional paid in capital.
For the nine months ended September 30, 2020, the increase in value
of the warrants due to the triggering events totaled $370,726 and
was properly included in the Company’s earnings per share amounts
on the accompanying statement of operations.
On August 21, 2020, the Company modified 2,222,222 warrants held by
two investors. Per the terms of the modifications, the Company
reduced the exercise price from $0.23 to $0.03 and extended the
term of the warrants to now expire on December 2, 2024. In
accordance with relevant accounting guidance, the Company valued
the warrants before and after modification. There was no change in
valuation due to the modifications.
8. Stock Options
The following table summarizes the Company’s stock options:
|
|
Number of
options
|
|
|
Weighted
average
exercise
price
|
|
|
Aggregate
intrinsic
value
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
December 31, 2019
|
|
|
5,690,000 |
|
|
$ |
0.13 |
|
|
|
|
Granted
|
|
|
- |
|
|
|
- |
|
|
|
|
Exercised
|
|
|
- |
|
|
|
- |
|
|
|
|
Cancelled /
forfeited
|
|
|
(2,290,000 |
) |
|
|
0.19 |
|
|
|
|
Balance,
September 30, 2020
|
|
|
3,400,000 |
|
|
$ |
0.09 |
|
|
$ |
- |
|
|
|
|
Outstanding
|
|
|
Exercisable
|
|
Range of
exercise prices
|
|
|
Number of
shares
|
|
|
Weighted average
remaining
contractual
life
(years)
|
|
|
Weighted
average
exercise
price
|
|
|
Number of
shares
|
|
|
Weighted
average
exercise
price
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.04
|
|
|
|
1,500,000 |
|
|
|
3.6 |
|
|
|
0.04 |
|
|
|
1,125,000 |
|
|
|
0.04 |
|
$ |
0.08
|
|
|
|
250,000 |
|
|
|
2.0 |
|
|
|
0.08 |
|
|
|
250,000 |
|
|
|
0.08 |
|
$ |
0.13
|
|
|
|
1,425,000 |
|
|
|
1.6 |
|
|
|
0.13 |
|
|
|
1,425,000 |
|
|
|
0.13 |
|
$ |
0.16
|
|
|
|
225,000 |
|
|
|
0.4 |
|
|
|
0.16 |
|
|
|
225,000 |
|
|
|
0.16 |
|
|
|
|
|
|
3,400,000 |
|
|
|
2.5 |
|
|
$ |
0.09 |
|
|
|
3,400,000 |
|
|
$ |
0.09 |
|
During the nine months ended September 30, 2020, the Company did
not issue any options to employees. During the nine months ended
September 30, 2020 and 2019, the Company recorded $15,000 and
$30,000, respectively, of stock-based compensation expense related
to stock option grants. As of September 30, 2020, the Company had
no unrecognized compensation expense.
9. Segments
The Company has one reportable segment: vehicle tracking and
recovery solutions. The Company allocates resources to and assesses
the performance of each reportable segment using information about
its revenue and operating income (loss). The Company does not
evaluate operating segments using discrete asset information.
Segmentation by geographical location is not presented as all
revenues are earned in U.S. Total assets by segment are not
presented as that information is not used to allocate resources or
assess performance at the segment level and is not reviewed by the
Chief Operating Decision Maker of the Company.
10. Risks & Uncertainties
The Company extends credit to customers on an unsecured basis in
the normal course of business. The Company’s policy is to perform
an analysis of the recoverability of its receivables at the end of
each reporting period and to establish allowances where
appropriate. The Company analyzes historical bad debts and contract
losses, customer concentrations, and customer credit-worthiness
when evaluating the adequacy of the allowances.
During the nine months ended September 30, 2020 and 2019, the
Company had three and one customers which accounted for 60% and
24%, respectively, of total invoiced amounts, which are recorded as
deferred revenues and amortized over the related service period to
revenues.
As of September 30, 2020 and December 31, 2019, the Company had one
and four customers, respectively, which accounted for 99% and 99%,
respectively, of the gross accounts receivable balance.
On January 30, 2020, the World Health Organization (“WHO”)
announced a global health emergency in response to a new strain of
a coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO
classified the COVID-19 outbreak as a pandemic based on the rapid
increase in exposure globally. The full impact of the COVID-19
outbreak continues to evolve as of the date of this report.
Management is actively monitoring the global situation and its
effects on the Company’s industry, financial condition, liquidity,
and operations. Through September 30, 2020, COVID-19 has had an
impact on the economy, the auto industry, and the Company’s 2020
revenue activity. Looking forward, it could continue to have a
material adverse effect on the Company’s business, financial
condition, liquidity, results of operations, and cash flows.
11. Commitments and
Contingencies
Indemnities and Guarantees
We have made certain indemnities and guarantees, under which we may
be required to make payments to a guaranteed or indemnified party,
in relation to certain transactions. We indemnify our officers and
directors to the maximum extent permitted under the laws of the
State of Nevada. The duration of these indemnities and guarantees
varies and, in certain cases, is indefinite. These indemnities and
guarantees do not provide for any limitation of the maximum
potential future payments we could be obligated to make.
Historically, we have not been obligated to make any payments for
these obligations and no liabilities have been recorded for these
indemnities and guarantees in the accompanying condensed
consolidated balance sheets.
Legal Matters
In the ordinary course of business, we may face various claims
brought by third parties and may, from time to time, make claims or
take legal actions to assert our rights, including intellectual
property disputes, contractual disputes and other commercial
disputes. Any of these claims could subject us to litigation.
Management believes there are currently no claims that are likely
to have a material effect on our consolidated financial position
and results of operations.
The Company has filed a lawsuit against a former distributor for
breach of contract resulting in losses to the Company estimated to
be in excess of $1,000,000. A court date has been set for
April 19, 2021.
12. Restatements
During 2019, we discovered that an accounting error had been made
related to the Company not properly recording contract assets as
required under the relevant accounting guidance for revenue
recognition. (As discussed in Note 1 “Revenue Recognition and
Deferred Revenue”, contract assets are netted with deferred
revenues for balance sheet presentation purposes.) It was
determined that the error is immaterial to the 2018 consolidated
financial statements; however, correcting the error related to 2018
in 2019 would materially misstate the condensed consolidated
financial statements for the three and nine months ended September
30, 2019. As such, we recorded the appropriate adjustment in 2018
and also computed the appropriate amounts related to September 30,
2019 and recorded such in the accompanying condensed consolidated
financial statements. See below for a summary of the corrections
made for this error:
Account
|
|
Previously
Recorded
Balance
|
|
|
Corrected
Balance
|
|
|
Correction
Made
|
|
|
|
|
|
|
|
|
|
|
|
For the three months
ended September 30, 2019:
|
|
|
|
|
|
|
|
|
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
Cost of
revenues
|
|
$ |
71,732 |
|
|
$ |
89,732 |
|
|
$ |
18,000 |
|
Net
loss
|
|
$ |
(635,582 |
) |
|
$ |
(653,582 |
) |
|
$ |
18,000 |
|
Loss per
share
|
|
$ |
(0.01 |
) |
|
$ |
(0.01 |
) |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine months ended
September 30, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
revenues
|
|
$ |
188,853 |
|
|
$ |
340,853 |
|
|
$ |
152,000 |
|
Net
loss
|
|
$ |
(829,695 |
) |
|
$ |
(981,123 |
) |
|
$ |
152,000 |
|
Loss per
share
|
|
$ |
(0.02 |
) |
|
$ |
(0.02 |
) |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
revenues, net
|
|
$ |
(253,381 |
) |
|
$ |
(101,381 |
) |
|
$ |
(152,000 |
) |
13. Subsequent Events
The Company evaluates subsequent events and transactions that occur
after the balance sheet date up to the date that the consolidated
financial statements are available to be issued. Any material
events that occur between the balance sheet date and the date that
the consolidated financial statements were available for issuance
are disclosed as subsequent events, while the consolidated
financial statements are adjusted to reflect any conditions that
existed at the balance sheet date. Based upon this review, except
as disclosed within the footnotes or as discussed below, the
Company did not identify any recognized or non-recognized
subsequent events that would have required adjustment or disclosure
in the consolidated financial statements.
In December 2019, a novel strain of coronavirus diseases
(“COVID-19”) was first reported in Wuhan, China. Less than four
months later, on March 11, 2020, the World Health Organization
declared COVID-19 a global pandemic. The extent of COVID-19’s
effect on the Company’s operational and financial performance will
depend on future developments, including the duration, spread and
intensity of the pandemic, all of which are uncertain and difficult
to predict considered the rapidly evolving landscape. The Company
is currently analyzing the potential impacts to its business.
Through September 30, 2020, COVID-19 has had an impact on the
economy, the auto industry, and the Company’s 2020 revenue
activity. Looking forward, it could continue to have a material
adverse effect on the Company’s business, financial condition,
liquidity, results of operations, and cash flows.
Subsequent to September 30, 2020, the Company issued a total of
18,053,645 shares of common stock for cash proceeds of $51,723.
Item
2. Management’s Discussion and Analysis of Financial Condition and
Results of Operations.
The following Management’s Discussion and Analysis of Financial
Condition and Results of Operations (“MD&A”) provides
information for the three and nine month periods ended September
30, 2020. This MD&A should be read together with our unaudited
condensed consolidated interim financial statements and the
accompanying notes for the three and nine month periods ended
September 30, 2019 (the “consolidated financial statements”). The
consolidated financial statements have been prepared in accordance
with generally accepted accounting principles in the United States
(“U.S. GAAP”). Except where otherwise specifically indicated, all
amounts in this MD&A are expressed in United States
dollars.
Certain statements in this MD&A constitute forward-looking
statements or forward-looking information within the meaning of
applicable securities laws. You should carefully read the
cautionary note in this MD&A regarding forward-looking
statements and should not place undue reliance on any such
forward-looking statements. See “Cautionary Note Regarding
Forward-Looking Statements”.
Additional information about the Company, including our most recent
consolidated financial statements and our Annual Information Form,
is available on our website at www.igen-networks.com, or on SEDAR
at www.sedar.com and on EDGAR at www.sec.gov.
Cautionary Note Regarding Forward-looking
Statements
Certain statements and information in this MD&A may not be
based on historical facts and may constitute forward-looking
statements or forward-looking information within the meaning of the
U.S. Private Securities Litigation Reform Act of 1995 and Canadian
securities laws (“forward-looking statements”), including our
business outlook for the short and longer term and our strategy,
plans and future operating performance. Forward-looking statements
are provided to help you understand our views of our short and
longer term prospects. We caution you that forward-looking
statements may not be appropriate for other purposes. We will not
update or revise any forward-looking statements unless we are
required to do so by securities laws. Forward-looking
statements:
|
☐
|
Typically
include words and phrases about the future such as “outlook”,
“may”, “estimates”, “intends”, “believes”, “plans”, “anticipates”
and “expects”;
|
|
☐
|
Are not
promises or guarantees of future performance. They represent our
current views and may change significantly;
|
|
☐
|
Are based
on a number of assumptions, including those listed below, which
could prove to be significantly incorrect:
|
|
-
|
Our ability
to find viable companies in which to invest
|
|
-
|
Our ability
successfully manage companies in which we invest
|
|
-
|
Our ability
to successfully raise capital
|
|
-
|
Our ability
to successfully expand and leverage the distribution channels of
our portfolio companies;
|
|
-
|
Our ability
to develop new distribution partnerships and channels
|
|
-
|
Expected
tax rates and foreign exchange rates.
|
|
☐
|
Are subject
to substantial known and unknown material risks and uncertainties.
Many factors could cause our actual results, achievements and
developments in our business to differ significantly from those
expressed or implied by our forward-looking statements. Actual
revenues and growth projections of the Company or companies in
which we are invested may be lower than we expect for any reason,
including, without limitation:
|
|
-
|
the
continuing uncertain economic conditions
|
|
-
|
price and
product competition
|
|
-
|
changing
product mixes,
|
|
-
|
the loss of
any significant customers,
|
|
-
|
competition
from new or established companies,
|
|
-
|
higher than
expected product, service, or operating costs,
|
|
-
|
inability
to leverage intellectual property rights,
|
|
-
|
delayed
product or service introductions
|
Investors are cautioned not to place undue reliance on these
forward-looking statements. No forward-looking statement is a
guarantee of future results.
Overview
During the nine months of 2020, the Company continues to focus on
initiatives to grow revenue, expand its customer base, and develop
new channels through its wholly owned subsidiary Nimbo Tracking LLC
and direct to customer brands Medallion GPS PRO and CU TRAK. In
addition to the Company’s Master Distributors and Sales Agents, all
three brands are marketed through the T-Mobile Business Program and
its Master Agent Hyperion Partners.
Notable highlights of the nine-month period ended September 30,
2020 include the following Company achievements:
The Company announced an exclusive and multi-year Nationwide
Partnership Agreement with County Executives of America
representing 700 Counties with over 450,000 self-insured commercial
assets.
The Company launched Medallion GPS PRO for Light-Commercial Fleets
with its Patent-Pending Digital Telematics Signature used for
normalizing and scoring of driver behavior based on actuarial
insurance metrics.
The Company signed a Sales & Marketing Agreement with Michigan
Credit Union League Service Corporation (“MCULSC”) for the
distribution of CU TRAK product line enabling Credit Unions to
finance more members, improve loan performance, and to provide
peace-of-mind for members and their families.
The Company launched the Next-Generation (NextGen) Platform for the
Consumer Automotive Markets that included IGEN’s Patented “Digital
Telematics Signature” for Universal Scoring of Driving Behavior.The
NextGen Platform establishes a framework for the Company to expand
its online presence along with expanding its customer base across
the consumer automotive markets.
The Company secured a Long-Term Equity Financing with Crown Bridge
Partners, LLC, and J.H. Darbie and Company Inc., as Placement Agent
and Investment Bank.
The Company signed a Partnership Agreement with T-Mobile’s Master
Agent Hyperion Partners for the sale of its products and services
through Hyperion Resellers, Referrers, and T-Mobile’s Business
Partner Program.
COVID-19
On January 30, 2020, the World Health Organization (“WHO”)
announced a global health emergency in response to a new strain of
a coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO
classified the COVID-19 outbreak as a pandemic based on the rapid
increase in exposure globally. The full impact of the COVID-19
outbreak continues to evolve as of the date of this report.
Management is actively monitoring the global situation and its
effects on the Company’s industry, financial condition, liquidity,
and operations. Through September 30, 2020, COVID-19 has had an
impact on the economy, the auto industry, and the Company’s 2020
revenue activity. Looking forward, it could continue to have a
material adverse effect on the Company’s business, financial
condition, liquidity, results of operations, and cash flows.
Financial Condition and Results of Operations
Capital Resources and Liquidity
Current Assets and Liabilities, Working Capital, Net
Debt
As of September 30, 2020, the Company’s current assets were
$36,483, an increase of 38% over the nine-month period.
Contributing to the net increase to current assets was the
borrowing of amounts under the PPP Loan and the SBA Loan offset by
a reduction in sales during the period as a result of COVID-19
impacting Franchise and Pre-Owned Automotive Dealerships and the
breach of terms of a distributor responsible for one of the
Company’s house accounts. The Company expects to recover this loss
business or receive monetary proceeds from settlement in 2020. The
Company will focus its sales efforts on higher-margin opportunities
across the T-Mobile/Sprint IoT Platform for all Company brands
along with a focus on County Executive and Credit Union
opportunities through recently announced partnerships.
Current liabilities increased $91,386, or 7%, over the nine months,
primarily due borrowings as noted above, and due to the derivative
liabilities that were established during 2019 and the nine months
ended September 30, 2020, and the amortization of debt issuance
costs.
The Company finished the nine-month period ended September 30,
2020, with a working capital deficiency of $1,359,270, a
deterioration of $81,386 over the nine months. Of the total working
capital deficiency, $106,282 is short-term deferred revenue
liabilities, net that will convert to revenues and cost of sales.
During the nine months ended September 30, 2020, the Company raised
a total of $629,269 in cash proceeds from (1) the sale of shares of
the Company’s common stock and series A preferred stock, (2) from
the proceeds of a PPP loan and SBA loan and (3) convertible notes.
The Company intends to improve its working capital position through
ongoing equity and debt financing and continued focus on growth in
its cash flow.
Total Assets and Liabilities, Total Stockholders’
Deficit
The Company’s total assets as of September 30, 2020 were $541,994,
an increase of $10,000 over the nine months. This increase was
commensurate with the respective changes in current assets
previously discussed.
Total liabilities increased $75,015 or 6% over the nine months.
This increase was composed primarily of $211,605 in loan
borrowings, the $10,304 increase in derivative liabilities, and
convertible debt, net, and a decrease of $127,891 of accounts
payable and deferred revenues, net, during the nine months.
The above resulted in total stockholders’ deficit of $927,729, an
increase of $68,527 from December 31, 2019. This change is a result
of the net loss and deemed dividends for the nine months ended
September 30, 2020, offset by the cash proceeds from the sale of
shares of the Company’s common stock and series A preferred stock
during the nine months.
As of the date of these financial statements, the Company requires
additional capital to maintain adequate working capital and
projected net revenues. The Company’s business plan is predicated
on raising further capital for the purpose of further investment
and acquisition of targeted technologies and companies, to fund
growth in these technologies and companies, and to expand sales and
distribution channels for companies it currently owns or is
invested. It is anticipated the Company will continue to raise
additional capital to fund growth and achieve profitability.
In December 2019, a novel strain of coronavirus diseases
(“COVID-19”) was first reported in Wuhan, China. Less than four
months later, on March 11, 2020, the World Health Organization
declared COVID-19 a global pandemic. The extent of COVID-19’s
effect on the Company’s operational and financial performance will
depend on future developments, including the duration, spread and
intensity of the pandemic, all of which are uncertain and difficult
to predict considered the rapidly evolving landscape. The Company
is currently analyzing the potential impacts to its business. At
this time, it is not possible to determine the magnitude of the
overall impact of COVID-19 on the Company. However, it could have a
material adverse effect on the Company’s business, financial
condition, liquidity, results of operations, and cash flows.
Results of Operations
Revenues and Net Loss For the Three Months Ended
September 30, 2020
Revenues
The Company had revenues of $77,996 for the three months ended
September 30, 2020, a 48% decrease over the similar period in 2019.
Sales decrease was attributed to COVID-19 and its impact on
Franchise and Pre-owned automotive dealerships along with the
breach of terms of a distributor responsible for one of the
Company’s house accounts. As stated in the CEO Outlook for 2020,
the Company expects resolution on breach of terms with its house
account along with additional revenue contribution from its new
partnerships with County Executives and MCULSC in late second half
of 2020.
The three-month gross profit of $34,878 representing 45% gross
margin compared to $60,275 and 40% gross margin over the similar
period in 2019. The Company continues to focus its sales efforts on
sales that generate higher than average margins.
The Company continues to review hardware, inventory, and order
fulfillment strategies as well as product and service pricing and
delivery models to grow sales and maximize overall margins.
Expenses
Operating expenses for the three months ended September 30, 2020
totaled $254,462 representing a 0% decrease in the operating
expenses reported in the same period in 2019. Included in other
income (expenses) for the three months ended September 30, 2020 and
2019 is $265,294 and ($94,122), respectively of change in fair
value of derivative liabilities. During the three months ended
September 30, 2020, the Company recorded a loss on the settlement
of debt totaling $29,582 for the conversions of debt. During the
three months ended September 30, 2020, the Company recorded $43,578
of interest expense related to its convertible debt and embedded
conversion feature. The Company anticipates increases in
development-associated labor and material costs as it completes the
launch of its next generation platform. The Company will also
expand its sales channels to support the T-Mobile Business Partner
Program and related initiatives.
Net Loss
The Company had a net loss of $27,450 for the three months ended
September 30, 2020, a decrease of $626,132 over the same period in
2019, for the reasons noted above.
The Company continues to invest in personnel, channels, and product
development in order to drive revenue growth and increase gross
profits sufficient to enable the Company to achieve
profitability.
Revenues and Net Loss For the Nine Months Ended
September 30, 2020
Revenues
The Company had revenues of $293,615 for the nine months ended
September 30, 2020, a 51% decrease over the similar period in 2019.
Sales decrease was attributed to COVID-19 and its impact on
Franchise and Pre-owned automotive dealerships along with the
breach of terms of a distributor responsible for one of the
Company’s house accounts. As stated in the CEO Outlook for 2020,
the Company expects resolution on breach of terms with its house
account along with additional revenue contribution from its new
partnerships with County Executives and MCULSC in late second half
of 2020.
The nine-month gross profit of $157,953 represents a 54% gross
margin compared to $253,032 and 43% gross margin over the similar
period in 2019. During the nine months ended September 30, 2020,
the Company had a one-time correction to the amounts owed its main
supplier of GPS units, resulting in a reduction of cost of sales of
approximately $20,000.
The Company continues to review hardware, inventory, and order
fulfillment strategies as well as product and service pricing and
delivery models to grow sales and maximize overall margins.
Expenses
Operating expenses for the nine months ended September 30, 2020
totaled $931,280 representing a 12% increase in the operating
expenses reported in the same period in 2019. This increase is due
to the value of the Series B preferred stock that was issued to
directors during the nine months ended September 30, 2020 and
valued at $277,543. Included in other income (expenses) for the
nine months ended September 30, 2020 and 2019 is $(1,082,407) and
$83,765, respectively of change in fair value of derivative
liabilities. During the nine months ended September 30, 2020, the
Company recorded a loss on the settlement of debt totaling $303,100
for the conversions of debt. During the nine months ended September
30, 2020, the Company recorded $351,085 of interest expense related
to its convertible debt and embedded conversion feature. The
Company anticipates increases in development-associated labor and
material costs as it completes the launch of its next generation
platform. The Company will also expand its sales channels to
support the T-Mobile Business Partner Program and related
initiatives.
Net Loss
The Company had a net loss of $2,509,919 for the nine months ended
September 30, 2020, an increase of $1,528,224 over the same period
in 2019, for the reasons noted above.
The Company continues to invest in personnel, channels, and product
development in order to drive revenue growth and increase gross
profits sufficient to enable the Company to achieve
profitability.
Cash Flows and Cash Position
The Company saw an increase in its ending cash balance of $23,920
over the nine months ended September 30, 2020. Net cash of $605,349
used in operating activities was offset by net financing cash of
$629,269 raised via private placements, PPP loan, SBA loan, and
from the issuance of convertible debt. Cash at the end of the
period was $23,920.
On July 27, 2020, the Company entered into an Equity Purchase
Agreement with an investor for working capital purposes. Per the
terms of the agreement, the investor will purchase up to $2,500,000
of the Company’s common stock at a 20% discount to the market price
or the valuation price (as defined). The Company has the right, but
not the obligation, to direct the investor to purchase put shares
of not less than $5,000 and not more than $175,000 or 200% of the
average daily trading value (as defined). During the nine months
ended September 30, 2020, the Company issues 8,000,000 shares of
common stock as a commitment fee on an equity line of credit with
an investor. As of September 30, 2020, $2,500,000 is available
under the Equity Purchase Agreement.
Item
3. Quantitative and Qualitative Disclosures About Market
Risk.
As a smaller reporting company, the Company is not required to
provide the information required by this item.
Item
4. Controls and Procedures.
Disclosure Controls and Procedures
The Company carried out an evaluation, with the participation of
all the Company’s officers, of the effectiveness of the Company’s
disclosure controls and procedures as of September 30, 2020. The
conclusions of the Company’s principal officers was that the
controls and procedures in place were not effective such that, the
information required to be disclosed in our exchange and commission
reports was a) recorded, processed, summarized and reported within
the time periods specified in the appropriate exchange and
commission rules and forms, and b) accumulated and communicated to
our management, including our chief executive offer and chief
operating officer, as appropriate to allow timely decisions
regarding required disclosure.
Internal Control over Financial Reporting
During the last fiscal quarter there was no change in the Company’s
internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the
Company’s internal control over financial reporting. In evaluating
the effectiveness of our internal control over financial reporting,
our management used the criteria set forth by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO) in
Internal Control - Integrated Framework (2013). We
identified the following material weakness:
☐
|
Our
discovery of an error that was corrected in 2019, to properly
account for our contract assets in accordance with relevant
accounting guidance for revenue recognition.
|
As additional resources become available, we will work to remediate
this identified material weakness.
Part
II
OTHER INFORMATION
Item 1.
Legal Proceedings
The Company has filed a lawsuit against a distributor for breach of
contract resulting in losses to the Company estimated to be in
excess of $1,000,000. A court date has been set for April 19,
2021.
Item 1A.
Risk Factors.
As a smaller reporting company, the Company is not required to
provide the information required by this item, however for a
discussion of risk factors affecting the Company please refer to
the Cautionary Note Regarding Forward-looking Statements
included in Part I Item 2 Management’s Discussion and Analysis of
Financial Condition and Results of Operations
Item 2.
Unregistered Sales of Equity Securities and Use of
Proceeds.
During the nine months ended September 30, 2020, the Company sold a
total of 26,750,000 shares of common stock for proceeds of
$151,250.
During the nine months ended September 30, 2020, the Company issued
a total of 903,534,383 shares of common stock for the conversion of
debt, accrued interest and fees, and the conversion of series A
preferred stock and accrued dividends.
During the nine months ended September 30, 2020, the Company issued
105,038,690 shares of common stock for the cashless exercise of
warrants.
During the nine months ended September 30, 2020, the Company issued
26,828,800 shares of common stock for the conversion of accrued
expenses owed to the CEO and VP of Operations.
On July 27, 2020, the Company entered into an Equity Purchase
Agreement with an investor. Per the terms of the agreement, the
investor will purchase up to $2,500,000 of the Company’s common
stock at a 20% discount to the market price or the valuation price
(as defined). The Company has the right, but not the obligation, to
direct the investor to purchase put shares of not less than $5,000
and not more than $175,000 or 200% of the average daily trading
value (as defined). During the nine months ended September 30,
2020, the Company issues 8,000,000 shares of common stock as a
commitment fee on an equity line of credit with an investor, which
was recorded as an offset to additional paid in capital in the
accompanying condensed consolidated financial statements.
During the nine months ended September 30, 2019, the Company sold a
total of 1,500,000 shares of common stock for proceeds of
$60,000.
During the nine months ended September 30, 2020, the Company issued
150,000 shares of common stock for services valued at $6,000.
On April 9, 2019 and separately on June 11, 2019, the Company
entered into a Series A Preferred Stock Purchase Agreement with an
investor. On April 9, 2019, the Company issued 86,000 shares for
net proceeds of $75,000 (after deducting $3,000 of direct legal
costs) and on June 11, 2019, the Company issued 58,300 shares for
net proceeds of $50,000 (after $3,000 deduction of direct legal
costs).
On September 17, 2019, the Company entered into a Series A
Preferred Stock Purchase Agreement with an investor. The Company
issued 58,300 shares for net proceeds of $50,000 (after $3,000
deduction of direct legal costs).
On February 25, 2020, the Company entered into a Series A Preferred
Stock Purchase Agreement with an investor. The Company issued
47,300 shares for proceeds of $43,000.
During the quarter ended June 30, 2020, the Company entered into
two Series A Preferred Stock Purchase Agreements with an investor.
The Company issued 100,100 shares for proceeds of $91,000.
During the quarter ended September 30, 2020, the Company entered
into two Series A Preferred Stock Purchase Agreements with an
investor. The Company issued 105,600 shares for proceeds of $96,000.
Item 3.
Defaults Upon Senior Securities.
There has been no material default in the payment of any element of
indebtedness of the Company. The Company has no preferred stock for
which dividends are paid, hence no related arrearage or
delinquencies in payments of dividends.
Item 4. Mine
Safety Disclosures.
The Company is not an operator, nor has a subsidiary that is an
operator, of a coal or other mine.
Item 5.
Other Information.
During the period covered by this report there was no information,
required to be disclosed in a report on Form 8-K, that was not
reported.
During the period covered by this report there were no material
changes to the procedures by which security holders may recommend
nominees to the registrant’s board of directors.
Item 6.
Exhibits.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
IGEN Networks Corp
|
|
|
|
|
|
November 16, 2020
|
By:
|
/s/
Neil Chan
|
|
|
|
Neil
Chan
|
|
|
|
Chief
Executive Officer and Director
|
|
|
|
(Principal
Executive Officer, Principal Financing
|
|
|
|
Officer and
Principal Accounting Officer)
|
|